SimpleTrials Expands Feature Set with Contracts and Payments
Oakland, Calif., Aug. 23, 2017 (Business Wire)-Trial By Fire Solutions, a leader in on-demand, web-based clinical trial management solutions that improve planning, execution and tracking of clinical studies, has released SimpleTrials 2.0, a clinical trial management system (CTMS) with new features such as site contracts and payments management. The release also offers updated subscription plans for the SimpleTrials CTMS to meet a greater variety of user needs for teams of all sizes and budgets.
SimpleTrials 2.0 handles complex contract scenarios and payment requirements, providing an effective and streamlined tool. Users can quickly build contract templates applicable to multiple sites. This streamlined contract capability allows effective oversight of international study needs, multiple contract types, and studies with different cohorts and complicated visit schedules. Payment features are seamlessly integrated with subject and visit tracking and include payment history and invoice generation.
-more-
A recent Pharma Tech Outlook article featured the company’s clinical software, which offers full transparency regarding pricing, legal agreements and subscriptions via the SimpleTrials website. Version 2.0 offers updated subscription plans that extend SimpleTrials’ affordability. The premium plan provides access to advanced features, and all plans now allow a greater number of studies.
“SimpleTrials 2.0 offers a low barrier to entry for budget-sensitive teams while delivering the robust functionality demanded by complex studies,” said Nancy Cecchettini, co-founder and chief product officer. “By combining our technology and product management expertise as well as direct clinical trial management experiences, contracts and payments can be managed directly within SimpleTrials, avoiding the need to utilize a separate payment system that can be costly and complicated.”
Sign up for a demo at simpletrials.com.
About SimpleTrials
Trial By Fire Solutions’ SimpleTrials is the first on-demand clinical trial management system (CTMS) in the life science industry. Designed by clinical experts, it is a subscription-based system that supports sponsors, sites, and vendors. Features include management of milestones, startup tracking, documents and eTMF, screening and enrollment, and site visit tracking plus reports and insights from dashboards. For more information, visit simpletrials.com.
About Trial By Fire Solutions
Trial By Fire Solutions is a global leader in web-based clinical trial management solutions and develops innovative applications to improve planning, execution and tracking of clinical studies. Since the release of its SimpleCTMS product, Trial By Fire Solutions has been providing affordable eClinical solutions to teams of all sizes.
CONTACT:
Lea Studer SCORR Marketing 308.237.5567
lea@scorrmarketing.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
